{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:58:00Z","timestamp":1791356280312,"version":"4.3.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T00:00:00Z","timestamp":1371686400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1038\/bjc.2013.295","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T18:43:50Z","timestamp":1371753830000},"page":"154-163","source":"Crossref","is-referenced-by-count":19,"title":["Tumour morphology predicts PALB2 germline mutation status"],"prefix":"10.1038","volume":"109","author":[{"name":"kConFab9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z L","family":"Teo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Provenzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G S","family":"Dite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D J","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Apicella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S D","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P A","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A H","family":"Trainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G J","family":"Lindeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Shackleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Cicciarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S S","family":"Buys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I L","family":"Andrulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Mulligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Glendon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E M","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M B","family":"Terry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F A","family":"Odefrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Nguyen-Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G G","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J G","family":"Dowty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Winship","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D E","family":"Goldgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J L","family":"Hopper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M C","family":"Southey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,20]]},"reference":[{"key":"BFbjc2013295_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/humu.10097","volume":"20","author":"IL Andrulis","year":"2002","unstructured":"Andrulis IL, Anton-Culver H, Beck J, Bove B, Boyd J, Buys S, Godwin AK, Hopper JL, Li F, Neuhausen SL, Ozcelik H, Peel D, Santella RM, Southey MC, van Orsouw NJ, Venter DJ, Vijg J, Whittemore AS (2002) Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations. Hum Mutat 20: 65\u201373.","journal-title":"Hum Mutat"},{"key":"BFbjc2013295_CR2","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72: 1117\u20131130.","journal-title":"Am J Hum Genet"},{"key":"BFbjc2013295_CR3","doi-asserted-by":"publisher","first-page":"R206","DOI":"10.1186\/bcr644","volume":"5","author":"C Apicella","year":"2003","unstructured":"Apicella C, Andrews L, Hodgson SV, Fisher SA, Lewis CM, Solomon E, Tucker K, Friedlander M, Bankier A, Southey MC, Venter DJ, Hopper JL (2003) Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a defined personal and family history in an Ashkenazi Jewish woman (LAMBDA). Breast Cancer Res 5: R206\u2013R216.","journal-title":"Breast Cancer Res"},{"issue":"11","key":"BFbjc2013295_CR4","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2335::AID-CNCR13>3.0.CO;2-N","volume":"83","author":"JE Armes","year":"1998","unstructured":"Armes JE, Egan AJ, Southey MC, Dite GS, McCredie MR, Giles GG, Hopper JL, Venter DJ (1998) The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations\u2014a population-based study. Cancer 83 (11): 2335\u20132345.","journal-title":"Cancer"},{"key":"BFbjc2013295_CR5","first-page":"2011","volume":"59","author":"JE Armes","year":"1999","unstructured":"Armes JE, Trute L, White D, Southey MC, Hammet F, Tesoriero A, Hutchins AM, Dite GS, McCredie MRE, Giles GG, Hopper JL, Venter DJ (1999) Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study. Cancer Res 59: 2011\u20132017.","journal-title":"Cancer Res"},{"key":"BFbjc2013295_CR6","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/humu.20415","volume":"27","author":"JL Bernstein","year":"2006","unstructured":"Bernstein JL, Teraoka S, Southey MC, Jenkins MA, Andrulis IL, Knight JA, John EM, Lapinski R, Wolitzer AL, Whittemore AS, West D, Seminara D, Olson ER, Spurdle AB, Chenevix-Trench G, Giles GG, Hopper JL, Concannon P (2006) Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T&gt;G and c.1066-6T&gt;G (IVS10-6T&gt;G) from the breast cancer family registry. Hum Mutat 27: 1122\u20131128.","journal-title":"Hum Mutat"},{"key":"BFbjc2013295_CR7","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10549-010-1290-4","volume":"126","author":"N Bogdanova","year":"2011","unstructured":"Bogdanova N, Sokolenko AP, Iyevleva AG, Abysheva SN, Blaut M, Bremer M, Christiansen H, Rave-Frank M, Dork T, Imyanitov EN (2011) PALB2 mutations in German and Russian patients with bilateral breast cancer. Breast Cancer Res Treat 126: 545\u2013550.","journal-title":"Breast Cancer Res Treat"},{"key":"BFbjc2013295_CR8","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/nsmb.1915","volume":"17","author":"R Buisson","year":"2010","unstructured":"Buisson R, Dion-Cote AM, Coulombe Y, Launay H, Cai H, Stasiak AZ, Stasiak A, Xia B, Masson JY (2010) Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination. Nat Struct Mol Biol 17: 1247\u20131254.","journal-title":"Nat Struct Mol Biol"},{"key":"BFbjc2013295_CR9","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1158\/0008-5472.CAN-10-3958","volume":"71","author":"S Casadei","year":"2011","unstructured":"Casadei S, Norquist BM, Walsh T, Stray S, Mandell JB, Lee MK, Stamatoyannopoulos JA, King MC (2011) Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. Cancer Res 71: 2222\u20132229.","journal-title":"Cancer Res"},{"key":"BFbjc2013295_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/94.3.205","volume":"94","author":"G Chenevix-Trench","year":"2002","unstructured":"Chenevix-Trench G, Spurdle AB, Gatei M, Kelly H, Marsh A, Chen XQ, Donn K, Cummings M, Nyholt D, Jenkins MA, Scott C, Pupo GM, Dork T, Bendix R, Kirk J, Tucker K, McCredie MRE, Hopper JL, Sambrook J, Mann GJ, Khanna KK (2002) Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst 94: 205\u2013215.","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc2013295_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2350-11-20","volume":"11","author":"A Dansonka-Mieszkowska","year":"2010","unstructured":"Dansonka-Mieszkowska A, Kluska A, Moes J, Dabrowska M, Nowakowska D, Niwinska A, Derlatka P, Cendrowski K, Kupryjanczyk J (2010) A novel germline PALB2 deletion in Polish breast and ovarian cancer patients. BMC Med Genet 11: 20.","journal-title":"BMC Med Genet"},{"key":"BFbjc2013295_CR12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10549-010-1271-7","volume":"126","author":"YC Ding","year":"2011","unstructured":"Ding YC, Steele L, Chu LH, Kelley K, Davis H, John EM, Tomlinson GE, Neuhausen SL (2011) Germline mutations in PALB2 in African-American breast cancer cases. Breast Cancer Res Treat 126: 227\u2013230.","journal-title":"Breast Cancer Res Treat"},{"key":"BFbjc2013295_CR13","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/jnci\/95.6.448","volume":"95","author":"GS Dite","year":"2003","unstructured":"Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MRE, Venter DJ, Hopper JL (2003) Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst 95: 448\u2013457.","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc2013295_CR14","doi-asserted-by":"publisher","first-page":"R122","DOI":"10.1186\/bcr3248","volume":"14","author":"GS Dite","year":"2012","unstructured":"Dite GS, Makalic E, Schmidt DF, Giles GG, Hopper JL, Southey MC (2012) Tumour morphology of early-onset breast cancers predicts breast cancer risk for first-degree relatives: the Australian Breast Cancer Family Registry. Breast Cancer Res 14: R122.","journal-title":"Breast Cancer Res"},{"key":"BFbjc2013295_CR15","doi-asserted-by":"publisher","first-page":"R465","DOI":"10.1186\/bcr1025","volume":"7","author":"H Eerola","year":"2005","unstructured":"Eerola H, Heikkila P, Tamminen A, Aittomaki K, Blomqvist C, Nevanlinna H (2005) Relationship of patients\u2019 age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families. Breast Cancer Res 7: R465\u2013R469.","journal-title":"Breast Cancer Res"},{"key":"BFbjc2013295_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1040-8428(99)00034-7","volume":"31","author":"CW Elston","year":"1999","unstructured":"Elston CW, Ellis IO, Pinder SE (1999) Pathological prognostic factors in breast cancer. Crit Rev Oncol Hematol 31: 209\u2013223.","journal-title":"Crit Rev Oncol Hematol"},{"key":"BFbjc2013295_CR17","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1158\/1078-0432.CCR-08-0210","volume":"14","author":"H Erkko","year":"2008","unstructured":"Erkko H, Dowty JG, Nikkila J, Syrjaekoski K, Mannermaa A, Pylkas K, Southey MC, Holli K, Kallioniemi A, Jukkola-Vuorinen A, Kataja V, Kosma VM, Xia B, Livingston DM, Winqvist R, Hopper JL (2008) Penetrance analysis of the PALB2 c.1592delT founder mutation. Clinical Cancer Res 14: 4667\u20134671.","journal-title":"Clinical Cancer Res"},{"issue":"6","key":"BFbjc2013295_CR18","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1186\/bcr1828","volume":"9","author":"WD Foulkes","year":"2007","unstructured":"Foulkes WD, Ghadirian P, Akbari MR, Hamel N, Giroux S, Sabbaghian N, Darnel A, Royer R, Poll A, Fafard E, Robidoux A, Martin G, Bismar TA, Tischkowitz M, Rousseau F, Narod SA (2007) Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women. Breast Cancer Res 9 (6): R83.","journal-title":"Breast Cancer Res"},{"key":"BFbjc2013295_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1365-2559.2006.02453.x","volume":"49","author":"LG Fulford","year":"2006","unstructured":"Fulford LG, Easton DF, Reis JS, Sofronis A, Gillett CE, Lakhani SR, Hanby A (2006) Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. Histopathology 49: 22\u201334.","journal-title":"Histopathology"},{"key":"BFbjc2013295_CR20","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1158\/1078-0432.CCR-08-3128","volume":"15","author":"T Heikkinen","year":"2009","unstructured":"Heikkinen T, Karkkainen H, Aaltonen K, Milne RL, Heikkila P, Aittomaki K, Blomqvist C, Nevanlinna H (2009) The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype. Clin Cancer Res 15: 3214\u20133222.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2013295_CR21","doi-asserted-by":"publisher","first-page":"E2176","DOI":"10.1002\/humu.21478","volume":"32","author":"H Hellebrand","year":"2011","unstructured":"Hellebrand H, Sutter C, Honisch E, Gross E, Wappenschmidt B, Schem C, Deissler H, Ditsch N, Gress V, Kiechle M, Bartram CR, Schmutzler RK, Niederacher D, Arnold N, Meindl A (2011) Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer. Hum Mutat 32: E2176\u2013E2188.","journal-title":"Hum Mutat"},{"key":"BFbjc2013295_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/PAT.0b013e32834e8e5b","volume":"44","author":"JL Hopper","year":"2012","unstructured":"Hopper JL, Jenkins MA, Dowty JG, Dite GS, Apicella C, Keogh L, Win AK, Young JP, Buchanan D, Walsh MD, Rosty C, Baglietto L, Severi G, Phillips KA, Wong EM, Dobrovic A, Waring P, Winship I, Ramus SJ, Giles GG, Southey MC (2012) Using tumour pathology to identify people at high genetic risk of breast and colorectal cancers. Pathology 44: 89\u201398.","journal-title":"Pathology"},{"key":"BFbjc2013295_CR23","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1200\/JCO.2005.01.9737","volume":"24","author":"PA James","year":"2006","unstructured":"James PA, Doherty R, Harris M, Mukesh BN, Milner A, Young MA, Scott C (2006) Optimal selection of individuals for BRCA mutation testing: a comparison of available methods. J Clin Oncol 24: 707\u2013715.","journal-title":"J Clin Oncol"},{"key":"BFbjc2013295_CR24","doi-asserted-by":"publisher","first-page":"R375","DOI":"10.1186\/bcr801","volume":"6","author":"EM John","year":"2004","unstructured":"John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, Ziogas A, Andrulis IL, Anton-Culver H, Boyd N, Buys SS, Daly MB, O'Malley FP, Santella RM, Southey MC, Venne VL, Venter DJ, West DW, Whittemore AS, Seminara D (2004) The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 6: R375\u2013R389.","journal-title":"Breast Cancer Res"},{"key":"BFbjc2013295_CR25","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/jnci\/90.15.1138","volume":"90","author":"SR Lakhani","year":"1998","unstructured":"Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van de Vijver MJ, Farid LM, Venter D, Antoniou A, Storfer-Isser A, Smyth E, Steel CM, Haites N, Scott RJ, Goldgar D, Neuhausen S, Daly PA, Ormiston W, McManus R, Scherneck S, Ponder BAJ, Ford D, Peto J, Stoppa-Lyonnet D, Bignon YJ, Struewing JP, Spurr NK, Bishop DT, Klijn JGM, Devilee P, Cornelisse CJ, Lasset C, Lenoir G, Barkardottir RB, Egilsson V, Hamann U, Chang-Claude J, Sobol H, Weber B, Stratton MR, Easton DF (1998) Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 90: 1138\u20131145.","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc2013295_CR26","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1200\/JCO.2002.09.023","volume":"20","author":"SR Lakhani","year":"2002","unstructured":"Lakhani SR, van de Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, McGuffog L, Easton DF (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20: 2310\u20132318.","journal-title":"J Clin Oncol"},{"key":"BFbjc2013295_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/modpathol.3800496","volume":"19","author":"TA Longacre","year":"2006","unstructured":"Longacre TA, Ennis M, Quenneville LA, Bane AL, Bleiweiss IJ, Carter BA, Catelano E, Hendrickson MR, Hibshoosh H, Layfield LJ, Memeo L, Wu H, O'Malley FP (2006) Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study. Mod Pathol 19: 195\u2013207.","journal-title":"Mod Pathol"},{"key":"BFbjc2013295_CR28","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1186\/bcr1377","volume":"8","author":"GJ Mann","year":"2006","unstructured":"Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E, Evans GM, Fereday S, Haan E, Gattas M, Giles GG, Goldblatt J, Hopper JL, Kirk J, Leary JA, Lindeman G, Niedermayr E, Phillips KA, Picken S, Pupo GM, Saunders C, Scott CL, Spurdle AB, Suthers G, Tucker K, Chenevix-Trench G (2006) Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8: R12.","journal-title":"Breast Cancer Res"},{"key":"BFbjc2013295_CR29","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/modpathol.2010.123","volume":"23","author":"F Marginean","year":"2010","unstructured":"Marginean F, Rakha EA, Ho BC, Ellis IO, Lee AHS (2010) Histological features of medullary carcinoma and prognosis in triple-negative basal-like carcinomas of the breast. Mod Pathol 23: 1357\u20131363.","journal-title":"Mod Pathol"},{"key":"BFbjc2013295_CR30","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/1055-9965.EPI-11-0775","volume":"21","author":"N Mavaddat","year":"2010","unstructured":"Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, Sinilnikova OM, Southey MC, Terry MB, Goldgar D, O'Malley F, John EM, Janavicius R, Tihomirova L, Hansen TV, Nielsen FC, Osorio A, Stavropoulou A, Benitez J, Manoukian S, Peissel B, Barile M, Volorio S, Pasini B, Dolcetti R, Putignano AL, Ottini L, Radice P, Hamann U, Rashid MU, Hogervorst FB, Kriege M, van der Luijt RB, Peock S, Frost D, Evans DG, Brewer C, Walker L, Rogers MT, Side LE, Houghton C, Weaver J, Godwin AK, Schmutzler RK, Wappenschmidt B, Meindl A, Kast K, Arnold N, Niederacher D, Sutter C, Deissler H, Gadzicki D, Preisler-Adams S, Varon-Mateeva R, Schonbuchner I, Gevensleben H, Stoppa-Lyonnet D, Belotti M, Barjhoux L, Isaacs C, Peshkin BN, Caldes T, de la Hoya M, Canadas C, Heikkinen T, Heikkila P, Aittomaki K, Blanco I, Lazaro C, Brunet J, Agnarsson BA, Arason A, Barkardottir RB, Dumont M, Simard J, Montagna M, Agata S, D'Andrea E, Yan M, Fox S, Rebbeck TR, Rubinstein W, Tung N, Garber JE, Wang X, Fredericksen Z, Pankratz VS, Lindor NM, Szabo C, Offit K, Sakr R, Gaudet MM, Singer CF, Tea MK, Rappaport C, Mai PL, Greene MH, Sokolenko A, Imyanitov E, Toland AE, Senter L, Sweet K, Thomassen M, Gerdes AM, Kruse T, Caligo M, Aretini P, Rantala J, von Wachenfeld A, Henriksson K, Steele L, Neuhausen SL, Nussbaum R, Beattie M, Odunsi K, Sucheston L, Gayther SA, Nathanson K, Gross J, Walsh C, Karlan B, Chenevix-Trench G, Easton DF, Antoniou AC (2010) Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1\/2 (CIMBA). Cancer Epidemiol Biomarkers Prev 21: 134\u2013147.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFbjc2013295_CR31","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/sj.bjc.6601293","volume":"89","author":"MRE McCredie","year":"2003","unstructured":"McCredie MRE, Dite GS, Southey MC, Venter DJ, Giles GG, Hopper JL (2003) Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status. Br J Cancer 89: 1661\u20131663.","journal-title":"Br J Cancer"},{"key":"BFbjc2013295_CR32","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1158\/0008-5472.CAN-09-0851","volume":"70","author":"J Mouchawar","year":"2010","unstructured":"Mouchawar J, Korch C, Byers T, Pitts TM, Li EF, McCredie MRE, Giles GG, Hopper JL, Southey MC (2010) Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian breast cancer family study. Cancer Res 70: 4795\u20134800.","journal-title":"Cancer Res"},{"key":"BFbjc2013295_CR33","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10549-008-0153-8","volume":"116","author":"SL Neuhausen","year":"2009","unstructured":"Neuhausen SL, Ozcelik H, Southey MC, John EM, Godwin AK, Chung W, Iriondo-Perez J, Miron A, Santella RM, Whittemore A, Andrulis IL, Buys SS, Daly MB, Hopper JL, Seminara D, Senie RT, Terry MB (2009) BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research. Breast Cancer Res Treat 116: 379\u2013386.","journal-title":"Breast Cancer Res Treat"},{"key":"BFbjc2013295_CR34","volume-title":"Infiltrating Carcinoma: Major Histological Types","author":"DL Page","year":"1987","unstructured":"Page DL, Anderson TJ, Sakamoto G (1987) Infiltrating Carcinoma: Major Histological Types. Churchill Livingstone: Edinburgh."},{"key":"BFbjc2013295_CR35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10689-009-9295-z","volume":"9","author":"L Papi","year":"2010","unstructured":"Papi L, Putignano AL, Congregati C, Piaceri I, Zanna I, Sera F, Morrone D, Genuardi M, Palli D (2010) A PALB2 germline mutation associated with hereditary breast cancer in Italy. Fam Cancer 9: 181\u2013185.","journal-title":"Fam Cancer"},{"key":"BFbjc2013295_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/ng1959","volume":"39","author":"N Rahman","year":"2007","unstructured":"Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T, Jayatilake H, McGuffog L, Hanks S, Evans DG, Eccles D, Easton DF, Stratton MR (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39: 165\u2013167.","journal-title":"Nat Genet"},{"key":"BFbjc2013295_CR37","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ng1947","volume":"39","author":"S Reid","year":"2007","unstructured":"Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, Neveling K, Kelly P, Seal S, Freund M, Wurm M, Batish SD, Lach FP, Yetgin S, Neitzel H, Ariffin H, Tischkowitz M, Mathew CG, D Auerbach A, Rahman N (2007) Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genetics 39: 162\u2013164.","journal-title":"Nat Genetics"},{"issue":"35","key":"BFbjc2013295_CR38","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.1200\/JCO.2012.41.7469","volume":"30","author":"S Sawyer","year":"2012","unstructured":"Sawyer S, Mitchell G, McKinley J, Chenevix-Trench G, Beesley J, Chen XQ, Bowtell D, Trainer AH, Harris M, Lindeman GJ, James PA (2012) A role for common genomic variants in the assessment of familial breast cancer. J Clin Oncol 30 (35): 4330\u20134336.","journal-title":"J Clin Oncol"},{"key":"BFbjc2013295_CR39","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.ejca.2007.01.011","volume":"43","author":"LD Smith","year":"2007","unstructured":"Smith LD, Tesoriero AA, Ramus SJ, Dite G, Royce SG, Giles GG, McCredie MRE, Hopper JL, Southey MC (2007) BRCA1 promoter deletions in young women with breast cancer and a strong family history: a population-based study. Eur J Cancer 43: 823\u2013827.","journal-title":"Eur J Cancer"},{"key":"BFbjc2013295_CR40","doi-asserted-by":"publisher","first-page":"R109","DOI":"10.1186\/bcr2796","volume":"12","author":"M Southey","year":"2010","unstructured":"Southey M, Teo Z, Dowty J, Odefrey F, Park D, Tischkowitz M, Sabbaghian N, Apicella C, Byrnes G, Winship I, Baglietto L, Giles G, Goldgar D, Foulkes W, Hopper J kConFab for the Breast Cancer Family Registry (2010) A PALB2 mutation associated with high risk of breast cancer. Breast Cancer Res 12: R109.","journal-title":"Breast Cancer Res"},{"key":"BFbjc2013295_CR41","doi-asserted-by":"publisher","first-page":"6524","DOI":"10.1200\/JCO.2005.04.671","volume":"23","author":"MC Southey","year":"2005","unstructured":"Southey MC, Jenkins MA, Mead L, Whitty J, Trivett M, Tesoriero AA, Smith LD, Jennings K, Grubb G, Royce SG, Walsh MD, Barker MA, Young JP, Jass JR, St John DJB, Macrae FA, Giles GG, Hopper JL (2005) Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol 23: 6524\u20136532.","journal-title":"J Clin Oncol"},{"key":"BFbjc2013295_CR42","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/bjc.2011.41","volume":"104","author":"MC Southey","year":"2011","unstructured":"Southey MC, Ramus SJ, Dowty JG, Smith LD, Tesoriero AA, Wong EEM, Dite GS, Jenkins MA, Byrnes GB, Winship I, Phillips KA, Giles GG, Hopper JL (2011) Morphological predictors of BRCA1 germline mutations in young women with breast cancer. Br J Cancer 104: 903\u2013909.","journal-title":"Br J Cancer"},{"key":"BFbjc2013295_CR43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/sj.bjc.6690008","volume":"79","author":"MC Southey","year":"1999","unstructured":"Southey MC, Tesoriero AA, Andersen CR, Jennings KM, Brown SM, Dite GS, Jenkins MA, Osborne RH, Maskiell JA, Porter L, Giles GG, McCredie MRE, Hopper JL, Venter DJ (1999) BRCA1 mutations and other sequence variants in a population based sample of Australian women with breast cancer. Br J Cancer 79: 34\u201339.","journal-title":"Br J Cancer"},{"key":"BFbjc2013295_CR44","unstructured":"StataCorp (2009) Stata Statistical Software: Release 11. StataCorp LP: College Station, TX."},{"key":"BFbjc2013295_CR45","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1073\/pnas.0811159106","volume":"106","author":"SMH Sy","year":"2009","unstructured":"Sy SMH, Huen MSY, Chen JJ (2009) PALB2 is an integral component of the BRCA complex required for homologous recombination repair. Proc Natl Acad Sci USA 106: 7155\u20137160.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbjc2013295_CR46","doi-asserted-by":"publisher","first-page":"R17","DOI":"10.1186\/bcr3392","volume":"15","author":"ZL Teo","year":"2013","unstructured":"Teo ZL, Park DJ, Provenzano E, Chatfield CA, Odefrey FA, Nguyen-Dumont T, Dowty JG, Hopper JL, Winship I, Goldgar DE, Southey MC (2013a) Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families. Breast Cancer Res 15: R17.","journal-title":"Breast Cancer Res"},{"key":"BFbjc2013295_CR47","doi-asserted-by":"crossref","unstructured":"Teo ZL, Sawyer SD, James PA, Mitchell G, Trainer AH, Lindeman GJ, Shackleton K, Cicciarelli L, Southey MC (2013b) The incidence of PALB2 c.3113G&gt;A in women with a strong family history of breast and ovarian cancer attending familial cancer centres in Australia. Fam Cancer; e-pub ahead of print 8 March 2013.","DOI":"10.1007\/s10689-013-9620-4"},{"key":"BFbjc2013295_CR48","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/humu.22022","volume":"33","author":"M Tischkowitz","year":"2012","unstructured":"Tischkowitz M, Capanu M, Sabbaghian N, Li L, Liang X, Vall\u00e9e MP, Tavtigian SV, Concannon P, Foulkes WD, Bernstein L WECARE Study Collaborative Group Bernstein JL, Begg CB (2012) Rare germline mutations in PALB2 and breast cancer risk: a population-based study. Hum Mutat 33: 674\u2013680.","journal-title":"Hum Mutat"},{"key":"BFbjc2013295_CR49","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.1158\/0008-5472.CAN-10-1012","volume":"70","author":"M Tischkowitz","year":"2010","unstructured":"Tischkowitz M, Xia B (2010) PALB2\/FANCN: recombining cancer and Fanconi anemia. Cancer Res 70: 7353\u20137359.","journal-title":"Cancer Res"},{"key":"BFbjc2013295_CR50","doi-asserted-by":"publisher","first-page":"6788","DOI":"10.1073\/pnas.0701724104","volume":"104","author":"M Tischkowitz","year":"2007","unstructured":"Tischkowitz M, Xia B, Sabbaghian N, Reis-Filho JS, Hamel N, Li GL, van Beers EH, Li LL, Khalil T, Quenneville LA, Omeroglu A, Poll A, Lepage P, Wong N, Nederlof PM, Ashworth A, Tonin PN, Narod SA, Livingston DM, Foulkes WD (2007) Analysis of PALB2\/FANCN-associated breast cancer families. Proc Natl Acad Sci USA 104: 6788\u20136793.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbjc2013295_CR51","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1365-2559.2007.02761.x","volume":"51","author":"GG Van den Eynden","year":"2007","unstructured":"Van den Eynden GG, Colpaert CG, Couvelard A, Pezzella F, Dirix LY, Vermeulen PB, Van Marck EA, Hasebe T (2007) A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation. Histopathology 51: 440\u2013451.","journal-title":"Histopathology"},{"key":"BFbjc2013295_CR52","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1158\/1078-0432.CCR-07-4397","volume":"14","author":"GG Van den Eynden","year":"2008","unstructured":"Van den Eynden GG, Smid M, Van Laere SJ, Colpaert CG, Van der Auwera I, Bich TX, van Dam P, den Bakker MA, Dirix LY, Van Marck EA, Vermeulen PB, Foekens JA (2008) Gene expression profiles associated with the presence of a fibrotic focus and the growth pattern in lymph node-negative breast cancer. Clin Cancer Res 14: 2944\u20132952.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2013295_CR53","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1200\/JCO.2011.39.5590","volume":"30","author":"AK Win","year":"2012","unstructured":"Win AK, Young JP, Lindor NM, Tucker KM, Ahnen DJ, Young GP, Buchanan DD, Clendenning M, Giles GG, Winship I, Macrae FA, Goldblatt J, Southey MC, Arnold J, Thibodeau SN, Gunawardena SR, Bapat B, Baron JA, Casey G, Gallinger S, Le Marchand L, Newcomb PA, Haile RW, Hopper JL, Jenkins MA (2012) Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol 30: 958\u2013964.","journal-title":"J Clin Oncol"},{"key":"BFbjc2013295_CR54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/ng1942","volume":"39","author":"B Xia","year":"2007","unstructured":"Xia B, Dorsman JC, Ameziane N, de Vries Y, Rooimans MA, Sheng Q, Pals G, Errami A, Gluckman E, Llera J, Wang W, Livingston DM, Joenje H, de Winter JP (2007) Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet 39: 159\u2013161.","journal-title":"Nat Genet"},{"key":"BFbjc2013295_CR55","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.molcel.2006.05.022","volume":"22","author":"B Xia","year":"2006","unstructured":"Xia B, Sheng Q, Nakanishi K, Ohashi A, Wu JM, Christ N, Liu XG, Jasin M, Couch FJ, Livingston DM (2006) Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell 22: 719\u2013729.","journal-title":"Mol Cell"},{"key":"BFbjc2013295_CR56","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.cub.2009.02.018","volume":"19","author":"F Zhang","year":"2009","unstructured":"Zhang F, Ma JL, Wu JX, Ye L, Cai H, Xia B, Yu XC (2009) PALB2 links BRCA1 and BRCA2 in the DNA-damage response. Curr Biol 19: 524\u2013529.","journal-title":"Curr Biol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2013295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2013295","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2013295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T09:15:09Z","timestamp":1684401309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2013295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,20]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["BFbjc2013295"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2013.295","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,20]]}}}